Apothecon Pharmaceuticals

Founded in 2007 primarily as an R&D company, Apothecon Pharmaceuticals, India has grown to specialize in manufacturing prime API drugs, their intermediates and formulations, aiming to provide high-quality medicines globally at affordable prices. Its portfolio spans key therapeutic segments including oncology, cardiology, antidotes, anesthetics and orphan drugs, with facilities inspected and approved by the US FDA, UK MHRA, WHO GMP, state GMP, and health ministries in Turkey and Yemen. Navinta LLC serves as its US counterpart, and Waymade PLC is its exclusive associate for finished dosage forms in the UK and Europe.